Bolt Biotherapeutics, Inc.(BOLT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BOLT Bolt Biotherapeutics, Inc.

休市中 08-16 16:00:00 EDT

0.6939

+0.0029

+0.42%

盘后0.6939

+0.00000.00%

18:38 EDT

最高0.7000	最低0.6810	成交量10.98万
今开0.6810	昨收0.6910	日振幅2.75%
总市值2,655万	流通市值1,493万	总股本3,826万
成交额7.54万	换手率0.51%	流通股本2,151万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BOLT","market":"US","secType":"STK","nameCN":"Bolt Biotherapeutics, Inc.","latestPrice":0.6939,"timestamp":1723838400000,"preClose":0.691,"halted":0,"volume":109792,"hourTrading":{"tag":"盘后","latestPrice":0.6939,"preClose":0.6939,"latestTime":"18:38 EDT","volume":22,"amount":15.18,"timestamp":1723847934875},"delay":0,"floatShares":21510631,"shares":38264843,"eps":-1.741096,"marketStatus":"休市中","marketStatusCode":7,"change":0.0029,"latestTime":"08-16 16:00:00 EDT","open":0.681,"high":0.7,"low":0.681,"amount":75360.14844671999,"amplitude":0.027496,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.741096,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724054400000},"adr":0,"listingDate":1612501200000,"adjPreClose":0.691,"postHourTrading":{"tag":"盘后","latestPrice":0.6939,"preClose":0.6939,"latestTime":"18:38 EDT","volume":22,"amount":15.18,"timestamp":1723847934875},"volumeRatio":0.954396},"requestUrl":"/m/hq/s/BOLT","defaultTab":"news","newsList":[{"id":"2459213955","title":"Bolt Biotherapeutics Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459213955","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459213955?lang=zh_cn&edition=full","pubTime":"2024-08-16 20:00","pubTimestamp":1723809639,"startTime":"0","endTime":"0","summary":"   * Bolt Biotherapeutics Inc   报告，截至6月底的季度调整后每股亏损46美分，高于去年同期的每股-48美分。五位分析师对该季度的平均预期是每股亏损 48 美分。华尔街预期为每股-66美分至-36美分。* 营收同比下降 11%，为 128 万美元；分析师预期为 89.15 万美元。* Bolt Biotherapeutics Inc公布的本季度每股收益为亏损56美分。* Bolt Biotherapeutics Inc 本季度股价下跌了 7.9%，今年迄今为止下跌了 38.3%。华尔街对 Bolt Biotherapeutics Inc 的 12 个月目标价中位数为 1.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bolt Biotherapeutics Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLT","BK4139"],"gpt_icon":0},{"id":"2459213606","title":"Bolt Biotherapeutics Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459213606","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459213606?lang=zh_cn&edition=full","pubTime":"2024-08-16 20:00","pubTimestamp":1723809639,"startTime":"0","endTime":"0","summary":"   * Bolt Biotherapeutics Inc   报告，截至6月底的季度调整后每股亏损46美分，高于去年同期的每股-48美分。五位分析师对该季度的平均预期是每股亏损 48 美分。华尔街预期为每股-66美分至-36美分。* 营收同比下降 11%，为 128 万美元；分析师预期为 89.15 万美元。* Bolt Biotherapeutics Inc公布的本季度每股收益为亏损56美分。* Bolt Biotherapeutics Inc 本季度股价下跌了 7.9%，今年迄今为止下跌了 38.3%。华尔街对 Bolt Biotherapeutics Inc 的 12 个月目标价中位数为 1.50 美元。本摘要由 LSEG 8 月 16 日 12:00 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bolt Biotherapeutics Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLT","BK4139"],"gpt_icon":0},{"id":"2459721374","title":"Bolt Biotherapeutics2024财年第二财季实现净利润-21.20百万美元，同比减少17.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459721374","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459721374?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:02","pubTimestamp":1723737774,"startTime":"0","endTime":"0","summary":"8月16日，Bolt Biotherapeutics公布财报，公告显示公司2024财年第二财季净利润为-21.20百万美元，同比减少17.39%；其中营业收入为1.28百万美元，同比减少10.49%，每股基本收益为-0.56美元。从资产负债表来看，Bolt Biotherapeutics总负债38.32百万美元，其中短期债务3.00百万美元，资产负债比为0.04，流动比率为4.29。机构评级：截至2024年8月16日，当前有2家机构对Bolt Biotherapeutics目标价做出预测，其中目标均价为1.75美元，其中最低目标价为1.50美元，最高目标价为2.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000309959be670&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000309959be670&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLT"],"gpt_icon":0},{"id":"2459212964","title":"Bolt Biotherapeutics Inc    预计每股亏损 30 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2459212964","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459212964?lang=zh_cn&edition=full","pubTime":"2024-08-14 19:02","pubTimestamp":1723633356,"startTime":"0","endTime":"0","summary":"   * Bolt Biotherapeutics Inc    预计将在11月7日公布截至2024年9月30日的业绩报告时显示季度收入下降(预计)    * 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于加利福尼亚州红木城的公司的营收预计将从去年同期的253万美元下降43.7%，至142.3万美元。* LSEG 分析师对 Bolt Biotherapeutics Inc 的平均预期是每股亏损 30 美分。* 华尔街对 Bolt Biotherapeutics Inc 的 12 个月目标价中位数为 1.25 美元，高于其最新收盘价 0.70 美元。8月14日 - 以往季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bolt Biotherapeutics Inc    预计每股亏损 30 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLT"],"gpt_icon":0},{"id":"2457737888","title":"Bolt Biotherapeutics盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457737888","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457737888?lang=zh_cn&edition=full","pubTime":"2024-08-08 02:38","pubTimestamp":1723055897,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日02时38分，Bolt Biotherapeutics股票出现异动，股价急速下挫5.08%。截至发稿，该股报0.690美元/股，成交量4.2771万股，换手率0.11%，振幅5.50%。Bolt Biotherapeutics股票所在的生物技术行业中，整体跌幅为2.21%。其相关个股中，G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为5158.07%、2643.19%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为101.30%、69.66%、62.37%。Bolt Biotherapeutics公司简介：Bolt Biotherapeutics Inc是一家临床阶段的免疫肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808023817941ff1ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808023817941ff1ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLT","BK4139"],"gpt_icon":0},{"id":"2456969283","title":"Bolt Biotherapeutics Inc    预计每股亏损 48 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456969283","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456969283?lang=zh_cn&edition=full","pubTime":"2024-08-02 20:49","pubTimestamp":1722602952,"startTime":"0","endTime":"0","summary":"   * Bolt Biotherapeutics Inc    将于8月5日公布截至2024年6月30日的财报，预计季度收入将下降()。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于加利福尼亚州红木城的公司预计营收将从去年同期的143万美元下降37.8%，至89.15万美元。* LSEG 分析师对 Bolt Biotherapeutics Inc 的平均预期是每股亏损 48 美分。* 华尔街对 Bolt Biotherapeutics Inc 的 12 个月目标价中值为 1.25 美元，高于其 0.74 美元的最新收盘价。8月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bolt Biotherapeutics Inc    预计每股亏损 48 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLT"],"gpt_icon":0},{"id":"2456915222","title":"Bolt Biotherapeutics盘中异动 股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456915222","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456915222?lang=zh_cn&edition=full","pubTime":"2024-08-01 00:44","pubTimestamp":1722444267,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日00时44分，Bolt Biotherapeutics股票出现波动，股价快速拉升5.47%。截至发稿，该股报0.770美元/股，成交量6.0361万股，换手率0.16%，振幅2.88%。Bolt Biotherapeutics股票所在的生物技术行业中，整体涨幅为1.27%。其相关个股中，Renovaro Inc.、Zevra Therapeutics, Inc.、木薯科学涨幅较大，Cns Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs较为活跃，换手率分别为455.31%、161.19%、141.91%，振幅较大的相关个股有Renovaro Inc.、Cns Pharmaceuticals, Inc.、Alpha Tau Medical Ltd C/Wts ，振幅分别为79.10%、52.15%、44.12%。Bolt Biotherapeutics公司简介：Bolt Biotherapeutics Inc是一家临床阶段的免疫肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801004427aefc7ea9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801004427aefc7ea9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLT"],"gpt_icon":0},{"id":"2440149087","title":"Bolt Biotherapeutics盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440149087","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440149087?lang=zh_cn&edition=full","pubTime":"2024-06-03 23:53","pubTimestamp":1717429991,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日23时53分，Bolt Biotherapeutics股票出现波动，股价急速上涨5.06%。截至发稿，该股报0.795美元/股，成交量8.3851万股，换手率0.22%，振幅3.70%。Bolt Biotherapeutics股票所在的生物技术行业中，整体涨幅为1.45%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Cingulate Inc C/Wts 10/12/2026 、Biocardia Inc C/Wts 06/08/2024涨幅较大，Bio-Path Holdings, Inc.、Scorpius Holdings, Inc.、Affimed N.V.较为活跃，换手率分别为2986.93%、110.10%、84.50%，振幅较大的相关个股有Affimed N.V.、Bio-Path Holdings, Inc.、硕迪生物，振幅分别为73.56%、72.82%、70.25%。Bolt Biotherapeutics公司简介：Bolt Biotherapeutics Inc是一家临床阶段的免疫肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603235311af8bb870&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603235311af8bb870&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLT","BK4139"],"gpt_icon":0},{"id":"2435688566","title":"BUZZ-Bolt Biotherapeutics 放弃先导药物开发后股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2435688566","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435688566?lang=zh_cn&edition=full","pubTime":"2024-05-16 01:04","pubTimestamp":1715792693,"startTime":"0","endTime":"0","summary":"    5月15日 - ** 癌症药物开发商博尔特生物治疗公司  股价下跌34.4%，创下86美分的历史新低** 该公司周二晚些时候表示，将停止其主要候选抗癌药物曲妥珠单抗imbotolimod的进一步开发，因为发现该药物达不到预定的成功标准。** 券商 H.C. Wainwright & Co 将 BOLT 的评级从 \"买入 \"下调至 \"中性\"，理由是该公司未来的药物开发目前还存在不确定性。** 同时，BOLT 公司任命现任首席财务官 Willie Quinn 为首席执行官** BOLT 将裁员约 50** 包括本交易日的走势在内，该股今年累计下跌约 21","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BUZZ","BOLT"],"gpt_icon":0},{"id":"2435691657","title":"Jones Trading：下调Bolt Biotherapeutics(BOLT.US)评级，由买入调整至持有评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435691657","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435691657?lang=zh_cn&edition=full","pubTime":"2024-05-16 00:11","pubTimestamp":1715789476,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BOLT","BK4139"],"gpt_icon":0},{"id":"2435520476","title":"HC Wainwright &amp; Co.：下调Bolt Biotherapeutics(BOLT.US)评级，由买入调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435520476","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435520476?lang=zh_cn&edition=full","pubTime":"2024-05-16 00:05","pubTimestamp":1715789100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BOLT","BK4139"],"gpt_icon":0},{"id":"2435385186","title":"Guggenheim：下调Bolt Biotherapeutics(BOLT.US)评级，由买入调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435385186","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435385186?lang=zh_cn&edition=full","pubTime":"2024-05-15 18:27","pubTimestamp":1715768860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BOLT"],"gpt_icon":0},{"id":"2435888786","title":"美国研究综述-Altus Power、Jack in the Box、Home Depot","url":"https://stock-news.laohu8.com/highlight/detail?id=2435888786","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435888786?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:18","pubTimestamp":1715757518,"startTime":"0","endTime":"0","summary":"    路透5月15日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Altus Power、Jack in the Box 和 Home Depot。* Jack in the Box Inc   ：Wedbush将目标价从78美元下调至68美元 * Home Depot Inc   ：TD Cowen将目标价从440美元下调至420美元 以下是路透周三报导的美国公司研究行动摘要。* Altus Power Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4133","BOLT","BK4130","OXY","HQI","HD","IE00BZ1G4Q59.USD","BK4581","BK4588","AVIR","PHUN","IE00BSNM7G36.USD","LU0820562030.AUD","LU1989772923.USD","BK4083","HLVX","NUVL","BK4185","BK4023","ANNX","IE0031619046.USD","IGT","VECO","LU1989772840.SGD","LU1093756168.USD","BK4154","PGNY","LQDA","SDHC","BK4534","RLYB","ANAB","BK4150","HROW","PACS","BK4088","BK4533","AMPS","BK4504","LU0823411888.USD","LU1496350502.SGD","CRIS","BK4139","BK4585","IE00B66KJ199.SGD","JACK","IE00BWXC8680.SGD","LU0868494617.USD","SG9999001440.SGD","BK4539"],"gpt_icon":0},{"id":"2435820688","title":"美国研究综述-Altus Power、Jack in the Box、Home Depot","url":"https://stock-news.laohu8.com/highlight/detail?id=2435820688","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435820688?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:18","pubTimestamp":1715757518,"startTime":"0","endTime":"0","summary":"    路透5月15日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Altus Power、Jack in the Box 和 Home Depot。* Jack in the Box Inc   ：Wedbush将目标价从78美元下调至68美元 * Home Depot Inc   ：TD Cowen将目标价从440美元下调至420美元 以下是路透周三报道的美国公司研究行动摘要。* Altus Power Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772923.USD","BK4504","IE00BSNM7G36.USD","LU0823411888.USD","CRIS","AVIR","BK4185","RLYB","BK4588","ANAB","IE0031619046.USD","BK4581","NUVL","LQDA","OXY","BK4533","BK4088","HQI","BK4083","LU1496350502.SGD","LU1093756168.USD","IE00BWXC8680.SGD","BK4154","BK4133","BK4585","BK4023","BK4139","PACS","BK4130","ANNX","JACK","HROW","LU1989772840.SGD","BK4539","IE00BZ1G4Q59.USD","IGT","PHUN","LU0868494617.USD","SG9999001440.SGD","BOLT","VECO","BK4534","LU0820562030.AUD","IE00B66KJ199.SGD","BK4150","AMPS","PGNY","HD","SDHC","HLVX"],"gpt_icon":0},{"id":"2435309187","title":"Bolt Biotherapeutics盘中异动 下午盘大幅下挫5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435309187","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435309187?lang=zh_cn&edition=full","pubTime":"2024-05-14 02:40","pubTimestamp":1715625635,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日02时40分，Bolt Biotherapeutics股票出现异动，股价大幅下挫5.56%。截至发稿，该股报1.19美元/股，成交量15.0379万股，换手率0.39%，振幅7.94%。Bolt Biotherapeutics股票所在的生物技术行业中，整体涨幅为1.29%。Bolt Biotherapeutics公司简介：Bolt Biotherapeutics Inc是一家临床阶段的免疫肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051402403587e8793c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051402403587e8793c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLT","BK4139"],"gpt_icon":0},{"id":"2434140850","title":"Bolt Biotherapeutics盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434140850","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434140850?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:43","pubTimestamp":1715352201,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日22时43分，Bolt Biotherapeutics股票出现异动，股价大幅拉升5.12%。截至发稿，该股报1.18美元/股，成交量1.2829万股，换手率0.03%，振幅1.79%。Bolt Biotherapeutics股票所在的生物技术行业中，整体涨幅为0.24%。Bolt Biotherapeutics公司简介：Bolt Biotherapeutics Inc是一家临床阶段的免疫肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510224321792708e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510224321792708e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLT"],"gpt_icon":0},{"id":"2432313604","title":"Bolt Biotherapeutics盘中异动 早盘股价大跌6.43%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432313604","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432313604?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:50","pubTimestamp":1714657857,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时50分，Bolt Biotherapeutics股票出现异动，股价急速下挫6.43%。截至发稿，该股报1.05美元/股，成交量4861股，换手率0.01%，振幅0.00%。Bolt Biotherapeutics股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为2464.88%、402.84%、106.51%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Aptevo Therapeutics Inc.，振幅分别为73.72%、30.89%、30.21%。Bolt Biotherapeutics公司简介：Bolt Biotherapeutics Inc是一家临床阶段的免疫肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502215057861eab19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502215057861eab19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLT"],"gpt_icon":0},{"id":"2430733780","title":"Bolt Biotherapeutics盘中异动 临近收盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430733780","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2430733780?lang=zh_cn&edition=full","pubTime":"2024-04-27 03:55","pubTimestamp":1714161325,"startTime":"0","endTime":"0","summary":"北京时间2024年04月27日03时55分，Bolt Biotherapeutics股票出现异动，股价快速跳水5.17%。截至发稿，该股报1.10美元/股，成交量11.9697万股，换手率0.31%，振幅8.62%。Bolt Biotherapeutics股票所在的生物技术行业中，整体涨幅为0.14%。Bolt Biotherapeutics公司简介：Bolt Biotherapeutics Inc是一家临床阶段的免疫肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042703552587e84429&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042703552587e84429&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLT"],"gpt_icon":0},{"id":"2428585656","title":"Solana 链上开发框架 BOLT","url":"https://stock-news.laohu8.com/highlight/detail?id=2428585656","media":"MetaCat","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428585656?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:59","pubTimestamp":1713405548,"startTime":"0","endTime":"0","summary":"BOLT 是一个链上开发框架，它简化了无需许可、可组合性且可以永久存在于区块链上的游戏的开发","market":"hk","thumbnail":"data:image/png;base64,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","type":0,"news_type":0,"thumbnails":["data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABgAAAAYCAYAAADgdz34AAAACXBIWXMAABYlAAAWJQFJUiTwAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAH5SURBVHgB7VXBUQJBEJxZqiykfFwGnhGIEQgZyEMt/HAbgRgBEIESwcLLAh+QgWQARCBmwAstq7h15m454Gr3OP7Mi73d6Z7p7R0ATnEgMM8hpd59AFEGCL34i1hS6kLKh9mhXHSDKk+Ii2etw4CWvuPYgiAmWq87UtYXuQn6/Y+W1roJoL0U0HeUhOLakJYTIBTtRuO+k0nAUiAWFAFXeE0kXZKj55Iilg7aBN4wn2bUcW23G9wHF59cGQHPCTjIo3E6l7slkuqGBOMDykMsTbfgPxUp5RKOCKVGhPHHJOW4k1WVMUTEgqXWIXAugioNlBrc2QikrC21PqsyOJMYTEClhrTQ03Rr6ej1Bl+wdROdXd3YC4nuccoGYTyBCK+8QQun1UzV/s4n+l10dFLnQiM3EVFLbLfQA2eElj2dcUfbPcGPJGbDlrGdJYpjiN5CEvSKn8a2k8ZRkf5aw4ugliax34FcIEZ8mekkvsAgeLyihBq1L1l/OzjnIhOzYbpsc2NTu8XgiIjBzyekBL/yxARiUyG/QCMDW2zqlssGPizvg4dJgZZRIUaQzBjsZQ0yY3EeE01znueVtI6KFFF7c1EmZqayeZSEhUszr3wDQwqsSfN6O42VMa6TQXYLGeOaSPsAv2+uO8v5h8Maa3//DyecuaQ7xVHxD4rDJjfZUTFuAAAAAElFTkSuQmCC"],"rights":{"source":"jinse_stock","url":"https://www.jinse.cn/blockchain/3681905.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.jinse.cn/blockchain/3681905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_stock","symbols":["BK4139","BOLT"],"gpt_icon":0},{"id":"2428748363","title":"基于BOLT框架构建有可重用组件和可定制逻辑的井字棋","url":"https://stock-news.laohu8.com/highlight/detail?id=2428748363","media":"MetaCat","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428748363?lang=zh_cn&edition=full","pubTime":"2024-04-17 13:59","pubTimestamp":1713333574,"startTime":"0","endTime":"0","summary":"除了抽象 Solana 和重用链上逻辑之外，我们对 BOLT 将为用户生成的逻辑和 mod 引入带来的可能性感到兴奋。","market":"other","thumbnail":"data:image/png;base64,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","type":0,"news_type":0,"thumbnails":["data:image/png;base64,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"],"rights":{"source":"jinse_stock","url":"https://www.jinse.cn/blockchain/3681810.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.jinse.cn/blockchain/3681810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_stock","symbols":["BK4139","BOLT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.boltbio.com","stockEarnings":[{"period":"1week","weight":-0.0096},{"period":"1month","weight":-0.0618},{"period":"3month","weight":-0.1249},{"period":"6month","weight":-0.4218},{"period":"1year","weight":-0.3913},{"period":"ytd","weight":-0.3804}],"compareEarnings":[{"period":"1week","weight":0.04},{"period":"1month","weight":-0.0047},{"period":"3month","weight":0.047},{"period":"6month","weight":0.1097},{"period":"1year","weight":0.2705},{"period":"ytd","weight":0.1662}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bolt Biotherapeutics, Inc.于2015年1月22日在特拉华州注册成立，名称为Bolt Therapeutics, Inc.，总部位于加利福尼亚州红木市。该公司于2015年7月29日更名为Bolt Biotherapeutics,Inc.。该公司是一家临床阶段的免疫肿瘤公司，开发利用先天性和适应性免疫系统的肿瘤靶向疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.061257},{"month":2,"riseRate":0.666667,"avgChangeRate":0.044268},{"month":3,"riseRate":0.5,"avgChangeRate":0.027277},{"month":4,"riseRate":0.25,"avgChangeRate":-0.206313},{"month":5,"riseRate":0.5,"avgChangeRate":-0.088439},{"month":6,"riseRate":0.25,"avgChangeRate":-0.045436},{"month":7,"riseRate":0.5,"avgChangeRate":-0.040459},{"month":8,"riseRate":0.25,"avgChangeRate":0.040923},{"month":9,"riseRate":0,"avgChangeRate":-0.17335},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.027907},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.11889},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.093341}],"exchange":"NASDAQ","name":"Bolt Biotherapeutics, Inc.","nameEN":"Bolt Biotherapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bolt Biotherapeutics, Inc.(BOLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bolt Biotherapeutics, Inc.(BOLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bolt Biotherapeutics, Inc.,BOLT,Bolt Biotherapeutics, Inc.股票,Bolt Biotherapeutics, Inc.股票老虎,Bolt Biotherapeutics, Inc.股票老虎国际,Bolt Biotherapeutics, Inc.行情,Bolt Biotherapeutics, Inc.股票行情,Bolt Biotherapeutics, Inc.股价,Bolt Biotherapeutics, Inc.股市,Bolt Biotherapeutics, Inc.股票价格,Bolt Biotherapeutics, Inc.股票交易,Bolt Biotherapeutics, Inc.股票购买,Bolt Biotherapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bolt Biotherapeutics, Inc.(BOLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bolt Biotherapeutics, Inc.(BOLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}